Inhaled Nitric Oxide in Severe Obesity

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

October 31, 2027

Study Completion Date

December 31, 2027

Conditions

ObesityRespiratory InsufficiencyHypoxemic Respiratory FailureNitric Oxide

Interventions

DEVICE

Nitric oxide

20ppm for 15 minutes delivered by INO max(Nitric Oxide) Company : INO therapeutics, Inc.

Trial Locations (1)

Massachusetts General Hospital, Boston

All Listed Sponsors

lead

Massachusetts General Hospital

OTHER

NCT06675435 - Inhaled Nitric Oxide in Severe Obesity | Biotech Hunter | Biotech Hunter